�To ease pain and numbness associated with diabetes, NewYork-Presbyterian/Weill Cornell physician-scientists are studying a drug antecedently used for depression to treat peripheral neuropathy. Diabetics often hurt from this condition because of high blood lettuce levels that damage mettle cells. Those with peripheral neuropathy often endure chronic pain, cramping and sleepless nights that prevent them from living a normal lifestyle.
But now, scientists believe that a dose called edronax may alleviate their symptoms. The deepen works by boosting the level of the neurotransmitter norepinephrine between nerve cells. But it also deeds by inhibiting the neurotransmitter's degradation inside the mettle, where it is stored within the cell for later use.
Dr. Bassem Masri -- a cardiologist and diabetes specialist at New York-Presbyterian/Weill Cornell and Helen and Robert Appel Clinical Scholar and help professor of clinical medicine at Weill Cornell Medical College -- is poring over the drug's effectiveness in a Phase II trial in subjects who have been diagnosed with diabetes for at least annual and world Health Organization have
